These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27663304)

  • 1. [Update on molecular classifications and new histological classification of bladder cancer].
    Varinot J; Furudoï A; Roupret M; Compérat E
    Prog Urol; 2016; 26(11-12):600-607. PubMed ID: 27663304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a molecular pathologic classification of urothelial carcinoma.
    Sjödahl G; Lövgren K; Lauss M; Patschan O; Gudjonsson S; Chebil G; Aine M; Eriksson P; Månsson W; Lindgren D; Fernö M; Liedberg F; Höglund M
    Am J Pathol; 2013 Sep; 183(3):681-91. PubMed ID: 23827819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular taxonomy for urothelial carcinoma.
    Sjödahl G; Lauss M; Lövgren K; Chebil G; Gudjonsson S; Veerla S; Patschan O; Aine M; Fernö M; Ringnér M; Månsson W; Liedberg F; Lindgren D; Höglund M
    Clin Cancer Res; 2012 Jun; 18(12):3377-86. PubMed ID: 22553347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
    Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
    BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer genomics.
    Siracusano S; Rizzetto R; Porcaro AB
    Urologia; 2020 May; 87(2):49-56. PubMed ID: 31942831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
    Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
    Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis.
    Kardoust Parizi M; Margulis V; Compe Rat E; Shariat SF
    Urol Oncol; 2021 Jan; 39(1):15-33. PubMed ID: 32900624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in bladder urothelial carcinogenesis].
    Pignot G; le Goux C; Bieche I
    Bull Cancer; 2015 Dec; 102(12):1020-35. PubMed ID: 26617115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary bladder tumours. The new 2004 WHO classification].
    Seitz M; Zaak D; Knüchel-Clarke R; Stief C
    Urologe A; 2005 Sep; 44(9):1073-86. PubMed ID: 16133226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
    Kamoun A; de Reyniès A; Allory Y; Sjödahl G; Robertson AG; Seiler R; Hoadley KA; Groeneveld CS; Al-Ahmadie H; Choi W; Castro MAA; Fontugne J; Eriksson P; Mo Q; Kardos J; Zlotta A; Hartmann A; Dinney CP; Bellmunt J; Powles T; Malats N; Chan KS; Kim WY; McConkey DJ; Black PC; Dyrskjøt L; Höglund M; Lerner SP; Real FX; Radvanyi F;
    Eur Urol; 2020 Apr; 77(4):420-433. PubMed ID: 31563503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2004 WHO classification of bladder tumors: a summary and commentary.
    Montironi R; Lopez-Beltran A
    Int J Surg Pathol; 2005 Apr; 13(2):143-53. PubMed ID: 15864376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    Sjödahl G; Eriksson P; Liedberg F; Höglund M
    J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
    Sjödahl G
    Methods Mol Biol; 2018; 1655():53-64. PubMed ID: 28889377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Subtypes of Bladder Cancer.
    McConkey DJ; Choi W
    Curr Oncol Rep; 2018 Aug; 20(10):77. PubMed ID: 30128829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
    Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
    Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difficulties of the new classification system for bladder cancer].
    Ghorra C; Nemr E; Vieillefond A
    J Med Liban; 2002; 50(4):180-3. PubMed ID: 15298479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.
    Kouba E; Cheng L
    Endocr Pathol; 2016 Sep; 27(3):188-99. PubMed ID: 27334654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtyping bladder cancer: Is it ready for clinical practice?
    Vakar Lopez F
    Turk J Med Sci; 2020 Nov; 50(SI-2):1677-1678. PubMed ID: 32336078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of bladder cancer genomics: What have we learned and how can we use it?
    Audenet F; Attalla K; Sfakianos JP
    Urol Oncol; 2018 Jul; 36(7):313-320. PubMed ID: 29573965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification and natural history of bladder tumors].
    Allory Y
    Rev Prat; 2014 Dec; 64(10):1365-6, 1368-71. PubMed ID: 25668829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.